Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.

Advanced Micro Devices Inc. (AMD) stock tumbled more than 3% in pre-market trading on Wednesday after HSBC analysts double ...

Shares of Absci on Wednesday jumped following a report on a $20 million investment from Advanced Micro Devices. The stock was up 27% to $3.89 in pre-market trading. Through Tuesday's close, shares ...

HSBC analyst Frank Lee sees that trend continuing, and lowered his price target on AMD shares by $90, to $110 per share, and ...

The $20 million deal gives the chip supplier a toehold in the life-sciences market, a strategy it plans to replicate in other industries.

Dell Technologies (NYSE: DELL) builds on decades of PC innovation with a new, simplified portfolio featuring on-device AI for ...

CES 2025 is undoubtedly the biggest tech event of the year and we're expecting an avalanche of news and announcements each ...

Advanced Micro Devices AMD at a press conference prior to CES 2025 unveiled new cutting-edge AI PC processors for consumers ...

Dell’s embrace of AMD for corporate PCs — it already uses the chipmaker for consumer devices — is another blow for Intel Corp ...

One of the Companies Benefiting is VERSES AI Inc. (CBOE: VERS) (OTCQB: VRSSF) ...

All part of the brand’s desire to “transform screens into adaptive, intelligent companions that simplify and enrich every day ...

In an internal test, AMD used the Ryzen AI Max+ 395 to run a version of the Llama 70B large language model. The company says ...